within Pharmacolibrary.Drugs.N_NervousSystem.N05B_Anxiolytics.N05BA22_Cloxazolam;
model Cloxazolam 
   extends Pharmacolibrary.Drugs.ATC.N.N05BA22;

  annotation(Documentation(
    info ="<html><body><p>Cloxazolam is a benzodiazepine derivative used as an anxiolytic and for the treatment of anxiety disorders. It has sedative and muscle-relaxant properties. The drug is no longer widely used in most countries and is not currently FDA-approved in the United States, but is still marketed in Japan and a few other countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated based on class similarity to other oral benzodiazepines (e.g., diazepam) given the absence of direct published PK studies for cloxazolam in the literature. Assumed for a typical healthy adult population, single oral dose.</p><h4>References</h4><ol><li><p>Lavene, D, et al., &amp; Rulliere, R (1980). [Pharmacokinetics of cloxazolam in man, after single and multiple oral doses (author&#x27;s transl)]. <i>Therapie</i> 35(4) 533â€“543. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6110252/&quot;>https://pubmed.ncbi.nlm.nih.gov/6110252</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Cloxazolam;
